NASDAQ: #ANIX
#AnixaBio moves closer to a Phase 2 trial for its breast cancer vaccine after positive Phase 1 results, taking over the IND from Cleveland Clinic.
prismmarketview.com/anixa-biosci...

Anixa Biosciences Completes Enrollment in Breast Cancer Vaccine Trial, H.C. Wainwright Reiterates Buy Rating Novel vaccine targets high-risk and triple-negative breast cancer, with promising early immune response data Anixa Biosciences (Nasdaq: ANIX) is making headl

#ANIX Biosciences has completed enrollment in its groundbreaking breast cancer vaccine trial, marking a key milestone in the fight against cancer.
#AnixaBio
prismmarketview.com/anixa-biosci...